Evofem Biosciences Inc

Change company Symbol lookup

Select an option...

EVFM Evofem Biosciences Inc

MTX Minerals Technologies Inc

NS-C NuStar Energy LP

DQ Daqo New Energy Corp

ITRI Itron Inc

PSA-I Public Storage

HSKA Heska Corp

SLGN Silgan Holdings Inc

DYNA Dynastar Holdings Inc

ELMWQ Electric Last Mile Solutions Equity Warrant Exp 24 Aug 2027 *W EXP 08/24/2027

Go

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is engaged in developing and commercializing products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). Its product, Phexxi vaginal gel, is a hormone-free, woman-controlled, on-demand prescription contraceptive gel for women. Its lead clinical program is evaluating Phexxi (using the investigational name EVO100) for the prevention of chlamydia and gonorrhea in women. EVO200 vaginal gel (EVO200), its investigational candidate for the reduction of recurrent bacterial vaginosis (BV), uses the same vaginal potential of hydrogen (pH) modulator platform as Phexxi. It also focuses on developing Multipurpose Prevention Technology (MPT) vaginal gel for indications, including the prevention of human immunodeficiency virus (HIV) in women through Orion Biotechnology Canada Ltd.